United States · FDA National Drug Code directory

Temozolomide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
47335-890_7c774570-443b-40da-8038-7cb550f92048
Product NDC
47335-890
Form
CAPSULE
Composition / generic term
Temozolomide
Labeler
Sun Pharmaceutical Industries, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20140213
Source listing expiry
20261231

Source-listed ingredients

  • TEMOZOLOMIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (47335-890-21) / 14 CAPSULE in 1 BOTTLE · 47335-890-21
  • 15 BLISTER PACK in 1 CARTON (47335-890-72) / 1 CAPSULE in 1 BLISTER PACK · 47335-890-72
  • 5 BLISTER PACK in 1 CARTON (47335-890-74) / 1 CAPSULE in 1 BLISTER PACK · 47335-890-74
  • 20 BLISTER PACK in 1 CARTON (47335-890-75) / 1 CAPSULE in 1 BLISTER PACK · 47335-890-75
  • 1 BOTTLE in 1 CARTON (47335-890-80) / 5 CAPSULE in 1 BOTTLE · 47335-890-80
  • 1 BOTTLE in 1 CARTON (47335-890-87) / 20 CAPSULE in 1 BOTTLE · 47335-890-87

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →